Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide Monotherapy in Kaposi Sarcoma
NCT04577755Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2022
- Primary completion
- Feb 2027
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in Kaposi sarcoma (KS), sponsored by National Cancer Institute. Started Mar 2022; status: active, not recruiting.
02
Drugs
pomalidomide
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT04577755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04577755.